Duke Street Bio Ltd, 2026-06-11
An SEC Form D private-offering notice from London, a $4,136,978 filer-stated offering target in Biotech. Filed 2026-06-11. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing next-generation cancer therapies targeting DNA damage response and immuno-oncology pathways.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Nirrin Technologies, Inc., 2026-06-15, $9.7M, Billerica, MA
- Commense Bio, Inc., 2026-06-12, $2.7M, Boulder, CO
- Anodyne Nanotech, Inc., 2026-06-11, $17.3M, Boston, MA
- Quince Therapeutics, Inc., 2026-06-11, $186.4M, South San Francisco, CA
- Ovelle Bio Corp., 2026-06-10, $9.2M, Dover, DE
- SalivIQ Diagnostics Inc., 2026-06-10, $2.5M, Harrisonburg, VA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.